Showing results (51-60 of 99) with videos related to
Sort By:
Pageof 10
Behavioral and Brain Functions : BBF|July 6, 2011
Modulation of cortisol responses to the DEX/CRH test by polymorphisms of the interleukin-1beta gene in healthy adultsDaimei Sasayama, Hiroaki Hori, Yoshimi Iijima, et al.Scientific Reports|January 6, 2016
Blood-based gene expression signatures of medication-free outpatients with major depressive disorder: integrative genome-wide and candidate gene analysesHiroaki Hori, Daimei Sasayama, Toshiya Teraishi, et al.Behavioral and Brain Functions : BBF|August 17, 2011
Possible association between interleukin-1β gene and schizophrenia in a Japanese populationDaimei Sasayama, Hiroaki Hori, Toshiya Teraishi, et al.Journal of Affective Disorders|June 22, 2012
Schizotypy and genetic loading for schizophrenia impact upon neuropsychological status in bipolar II and unipolar major depressive disordersHiroaki Hori, Junko Matsuo, Toshiya Teraishi, et al.CNS Drugs|October 18, 2024
A Multicenter, Open-Label Study to Evaluate the Long-term Safety and Efficacy of Adjunctive Brexpiprazole 2 mg Daily in Japanese Patients with Major Depressive DisorderMasaki Kato, Masako Shiosakai, Kazuo Kuwahara, et al.Scientific Reports|November 4, 2015
(13)C-tryptophan breath test detects increased catabolic turnover of tryptophan along the kynurenine pathway in patients with major depressive disorderToshiya Teraishi, Hiroaki Hori, Daimei Sasayama, et al.Journal of Affective Disorders|June 3, 2014
Characteristic distributions of regional cerebral blood flow changes in major depressive disorder patients: a pseudo-continuous arterial spin labeling (pCASL) studyMiho Ota, Takamasa Noda, Noriko Sato, et al.Journal of Psychiatric Research|April 30, 2011
Poor sleep is associated with exaggerated cortisol response to the combined dexamethasone/CRH test in a non-clinical populationHiroaki Hori, Toshiya Teraishi, Daimei Sasayama, et al.Journal of Psychiatric Research|March 26, 2010
Relationships between psychological distress, coping styles, and HPA axis reactivity in healthy adultsHiroaki Hori, Yuji Ozeki, Toshiya Teraishi, et al.Psychiatry and Clinical Neurosciences|April 23, 2021
Efficacy and safety of lurasidone in acutely psychotic patients with schizophrenia: A 6-week, randomized, double-blind, placebo-controlled studyMasaomi Iyo, Jun Ishigooka, Masatoshi Nakamura, et al.Pageof 10